Whitehawk Therapeutics (WHWK) Stock: Buy, Sell, or Hold?
WHWK - Whitehawk Therapeutics, Inc. Common Stock
$3.70
-0.06 (-1.60%)
▼
5d:
-1.07%
30d:
-21.44%
90d:
-7.96%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When WHWK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: WHWK shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: WHWK shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: WHWK is currently trading at $3.70, which is considered oversold relative to its 30-day fair value range of $3.81 to $4.55.
Technical Outlook: Technically, WHWK is showing sideways momentum. The price is currently testing key support at $3.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: WHWK scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.71 (+108.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, WHWK is showing sideways momentum. The price is currently testing key support at $3.66. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: WHWK scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.71 (+108.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.81 -
$4.55
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 108.5% below Wall St target ($7.71)
- CAUTION: Bottoming setup, but lagging the sector by 34% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$3.81 -
$4.55
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.66
Resistance Level
$4.20
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.75
Wall Street Target
$7.71
(+108.5%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: October 04, 2026 2:22 AM ET
Data refreshes hourly during market hours. Next update: 3:22 AM
Data refreshes hourly during market hours. Next update: 3:22 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WHWK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott M Giacobello
SELL
141600 shares
2026-04-16
Scott M Giacobello
SELL
77000 shares
2026-04-15
Bryan Ball
SELL
92460 shares
2026-04-14
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 48 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 67 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$32 | 62 BUY |